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Abstract 
Metabolomic data sets provide a direct read-out of cellular phenotypes and are increasingly 
generated to study biological questions. Our previous work revealed the potential of analyzing 
extracellular metabolomic data in the context of the metabolic model using constraint-based 
modeling. Through this work, which consists of a protocol, a toolbox, and tutorials of two use 
cases, we make our methods available to the broader scientific community. The protocol 
describes, in a step-wise manner, the workflow of data integration and computational analysis. 
The MetaboTools comprise the Matlab code required to complete the workflow described in 
the protocol. Tutorials explain the computational steps for integration of two different data sets 
and demonstrate a comprehensive set of methods for the computational analysis of metabolic 
models and stratification thereof into different phenotypes. The presented workflow supports 
integrative analysis of multiple omics data sets. Importantly, all analysis tools can be applied 
to metabolic models without performing the entire workflow. Taken together, this protocol 
constitutes a comprehensive guide to the intra-model analysis of extracellular metabolomic 
data and a resource offering a broad set of computational analysis tools for a wide biomedical 
and non-biomedical research community.  
 
 
1. Introduction 
Omics data are used to determine comprehensively qualitatively or quantitatively cellular 
components and how they change across different conditions [1-4]. Of those, metabolomic data 
are the closest to an observed phenotype [5-7]. Consequently, metabolomics is becoming an 
indispensable analytical method for many biological disciplines, including microbiology, plant 
sciences, biotechnology, and biomedicine [8-10].  
 
However, the analysis and interpretation of metabolomics data is still in its infancy, limiting 
the interpretation to few metabolic pathways rather than providing a comprehensive 
understanding of the underlying mechanistic basis [1]. At the same time, computational 
modeling methods, such as constraint-based metabolic modeling [11], are becoming 
increasingly popular for the interpretation of omics data [12] and for the generation of 
experimentally testable hypotheses [13-15].  
 
Metabolomics data can be obtained from quenched cells (intracellular metabolome) or from 
the spent medium of cells in culture (extracellular metabolomic data). Extracellular 
metabolomic data sets are generated from cultivations of cell lines in order to metabolically 
characterize them under different experimental conditions (e.g., drug treatment and hypoxia) 
[16-18]. The extracellular metabolome captures metabolite consumption and byproduct 
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release, e.g., lactate secretion by cancer cells, which can be interpreted as readout of the 
intracellular pathway use, such as aerobic glycolysis in cancer cells [7]. Whereas the 
connection between lactate and glycolytic flux is quite straightforward, the integration of entire 
uptake and secretion profiles can lead to novel insights of complex interactions between 
multiple pathways, which may be difficult to unveil manually. Previously, the intra-model 
analysis of extracellular metabolomic data of two T-cell lines let to the prediction of phenotypic 
properties of the cell lines, namely differences in flux through the TCA cycle and the electron 
transport chain, which were subsequently experimentally supported [7]. Computational 
analysis enables the prediction of the intracellular pathway activity that explain the measured 
metabolite uptake and secretion pattern and differences thereof between, e.g., cell lines or 
environmental conditions, and can lead to experimentally testable hypothesis. 
 
The advantage of using extracellular metabolomic data lies in the accessibility of the medium, 
which saves time in sample preparation and allows for repeated measurements from the same 
cells. Moreover, concentration changes in the spent medium resulting from uptake and 
secretion by the cells can be converted into fluxes and used as constraints on the exchange 
reactions.  
 
Extracellular metabolomic data have been extensively used in metabolic modeling to define 
cell and tissue specific exchange pattern [4, 19-23]; however, the process has never been 
addressed by a protocol explicitly. In comparison to the integration of transcriptomics data with 
metabolic models [24, 25], tools for integration of metabolomics data have not yet been made 
assessable to a broader research community. Some methods for the generation of 
contextualized metabolic submodels allow consideration of intracellular metabolomics data 
and the presence of reactions producing a set of detected metabolites is ensured [26-28]. 
However, the downstream analysis of contextualized metabolic submodels and their predicted 
metabolic phenotypes is not supported by these methods. The constraint-based modeling and 
analysis (COBRA) toolbox [29] provides an extensive set of functions for the computational 
analysis of metabolic models and a tutorial is available assisting in the interpretation of model 
predictions [30]. Despite the presence of these resources, a step-by-step guide, which captures 
the entire workflow of data analysis and phenotype prediction, is currently not available. With 
this protocol, the MetaboTools, and the accompanied tutorials, we close this gap and make a 
comprehensive set of methods available to the broader research community (Figure 1).  
 
This work was developed and tested with our recent work [7], where we integrated extracellular 
metabolomic data of two T-cell lines with a human metabolic model to characterize the 
emergent phenotypic properties in silico. Furthermore, we recently mapped published 
metabolomic data from the NCI-60 cell lines [31] onto a human metabolic model and 
developed a suite of computational analysis tools that can be used to predict distinct metabolic 
features, e.g., the use of distinct pathways for energy production by the cancer cell lines [32]. 
The protocol discusses important considerations at individual steps to ensure successfully 
completion of the workflow (Figure 1). The tips and stipulations are derived from the 
aforementioned publications but also from our experience with curation and expansion of the 
human metabolic model using metabolomic data [33-35]. 
 
This protocol covers: This protocol provides support for the integration of metabolomics data 
into the network context and the generation of contextualized models. These contextualized 
models comprise a subset of the metabolic model and are primed to the prediction of the 
intracellular pathways, which may give rise to differences in the uptake and secretion profile 
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of different cells or under different environmental conditions, using the minExCard method 
[32]. Additionally, this work provides tools for the analysis of any metabolic model. 
 
The tutorials exemplify the workflows for intra-model analysis for (1) quantitative and (2) 
semi-quantitative extracellular metabolomic data (Figure 1, see also supplemental tutorial I and 
tutorial II), and make it facilitate the reproduction of our previous work [7, 32]. Importantly, 
the tutorials demonstrate the downstream analysis of the generated models. Additionally, we 
provide the data that are needed for the different integration steps (Table 1) and we discuss 
traits of metabolomic data sets to provide for a basis for their successful integration into the 
metabolic model (Table S1). 
 
This protocol does not cover: The protocol provides limited discussion on the integration of 
other omics data. The compatibility of MetaboTools with the COBRA toolbox [29] allows the 
user to apply additionally the transcriptomic data analysis tools provided in the COBRA 
toolbox [29]. The protocol does not describe the intra-model analysis of intracellular 
metabolomic, untargeted metabolomic, or isotope labeling data. Furthermore, this protocol 
does not cover any steps concerning cell culture, mass spectrometry, data processing, and 
metabolite annotations. We ask the reader to refer to literature and dedicated tools from the 
respective fields [36-38].  
 
2. Experimental design 
 
The protocol is divided into three stages. The first stage provides the basis for the integration 
of extracellular metabolomic data, i.e., it ensures that a maximal number of metabolites can be 
integrated with a model. The second stage discusses the application of constraints and the 
generation of contextualized models. The third stage discusses the quality control of the 
contextualized models, the computational analysis tools provided by MetaboTools, and finally 
the validation of the model predictions. Several iterations of the steps in the second and the 
third stage may be needed to generate high-quality contextualized models and to obtain 
biologically-plausible model predictions (Table 2). Throughout the text, functions are written 
in italic. Input and output variables are indicated by asterisks (*…*). Matlab code is indicated 
through >>. Flux units are commonly reported in the Unit mmol/gdry weight/hr (U); however, the 
unit can be varied depending on data [32]. 
 
Stage 1 - Preparation of extracellular metabolomics data and models. 
 
Associate metabolite IDs of the data with the metabolic model (Step 1): As a first step, the 
names of detected metabolites need to be associated with the metabolite abbreviations in the 
model (Figure 2A, see supplemental material for an introduction to the model structure). 
Different standards exist to report metabolite identity and the human genome-scale 
reconstruction contains annotations for multiple identifiers, e.g., KEGG [39], ChEBI [40], 
HMDB [41], because none of the databases covers all its metabolites [35]. Association of a 
detected metabolite with a wrong counterpart in the model can lead to irrelevant predictions 
and conclusions. Moreover, new reactions might be introduced into the model as a consequence 
of the association and reused by researchers in or outside the working group, often without 
questioning why these reactions were added (Figure 2C). Hence, manual association of  the 
metabolite identifiers is the method of choice, even though tools have been developed to 
facilitate the matching (e.g., [42]). The association is simplest based on, e.g., KEGG or HMDB 
metabolite identifiers. When matching metabolite names, one should consider synonyms and 
alternative naming conventions, e.g., palmitic acid is the traditional name of hexadecanoic acid 
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(common name). Metabolite formulae are non-unique, and thus can only be used as additional 
clue to match metabolites, e.g., glucose and fructose have both C6H12O6 as formula. 
 
The step results in one group of metabolites successfully associated with model metabolite IDs 
and a second group of metabolites that does not yet exist in the metabolic model. The addition 
of novel anabolic or catabolic pathways to include the latter group of metabolites into the model 
can be time-consuming and requires extensive work as well as testing of the model 
functionality. The necessary steps have been described in detail elsewhere [43]. Thus, only the 
steps needed to prepare the integration of associated metabolites will be considered in this 
protocol.   
 
Can metabolites be transported into and out of the cell? (Step 2): Although a metabolite is 
present in the model, this does not mean that it can be transported between the intracellular [c] 
and the extracellular [e] compartment (Figure 3A). Hence, it needs to be confirmed that 
transport reactions exist for all associated metabolites (Figure 2B). Transport reactions (e.g., 
ATP-dependent transport) can be irreversible, and transport reactions might need to be added 
that allow secretion or uptake of a metabolite. One exchange reaction needs to exist in the 
model for every associated metabolite (Figure 2B), since these (artificial) reactions mediate the 
supply or removal of metabolites to and from the extracellular environment of the model. These 
exchange reactions are used for the integration of extracellular metabolomic data into the model 
(Figure 3B).  
 
Identify missing metabolite transporter (Step 3): Metabolomic data sets often contain 
metabolites, for which no transport and exchange reactions exist in the models, since i) high-
throughput techniques detect more and more comprehensively metabolites in extracellular 
environments (e.g., body fluids or spent medium), ii) these metabolites were outside the scope 
of previous reconstruction efforts and applications [34], iii) their existence was unknown, or 
iv) their metabolism was unknown (Figure 2B, 3A).   
 
The correct representation of transport mechanisms is important to accurately simulate cellular 
metabolism; thus, the metabolic reconstructions are continuously extended [7, 34, 35, 44, 45]. 
Hence, before getting started with this step, ensure that the most recent reconstruction version 
is obtained (e.g., the human metabolic reconstruction is downloadable from 
https://vmh.uni.lu/).  
 
If extracellular transport reactions are missing for certain metabolites, they need to be identified 
from the literature. The identification of transport systems can take considerable time, which 
varies, depending on the number of metabolites and the extent to which the corresponding 
transport systems have been characterized [34]. Diffusion reactions should only be added if the 
transport system is unknown or diffusion of the metabolite has been reported. The model can 
use diffusion reactions to transport the metabolite “for free”. As a consequence, energy and 
material costs of the metabolite transport will be underestimated in simulations.  Thus, the 
exact transport mechanisms, all alternate and co-substrates, transport proteins, isozymes and 
ratio of subunits in protein complexes and their encoding genes, need to be identified. Correct 
gene-protein-reaction associations (see Box 1) are particularly important for integrating 
transcriptomic or proteomic data as well as for investigating  the effect of genetic alternation 
in metabolite transporters. After the literature has been mined thoroughly, the new mass- and 
charge-balanced transport reactions have to be formulated [43] and the transport reactions need 
to be added to the model (Figure 2C). References to the primary studies, on which the addition 
of the transporter is based, should be documented [43].  
5 
 
 
Addition of the transport and exchange reactions (Step 4): Transport reaction should be 
added in a quality controlled manner to avoid typos in the metabolite abbreviations or 
whitespaces in the reaction formula. Typos easily go unnoticed until much later, since the 
functions to add reactions in the COBRA toolbox also automatically add new metabolites. 
Hence, reactions should be added in a quality controlled manner using rBioNet [46]. The 
addition of reactions (and metabolites) to the source SBML file is discouraged as they 
circumvent any quality-assurance and quality-control measures, and as such, are often a source 
of errors in the resulting model. 
 
Stage 2 - Addition of constraints and model generation 
 
Define basic constraints (Step 5): Metabolic networks are often distributed as reconstructions 
and not as condition-specific models. Hence, exchange and internal reactions are 
unconstrained, i.e., they have “infinite bounds” (Figure 4, Box 1, supplemental material). 
Alternatively, models may be distributed that mimick with their constraints a particular 
environmental or genetic condition, e.g., enabling growth on minimal medium under anoxic 
condition. Hence, the existing constraints of a reconstruction or model may not be a useful 
starting point for the one’s own application. Whereas the directionality of transport reactions 
and internal reactions is consistent with current biological and thermodynamical data, the 
definition of the extracellular medium, i.e., the constraints on the exchange reactions (Figure 
4), depends on the cell type and condition one wants to simulate. The application of a context-
specific set of constraints on the exchange reactions ensures, together with the network 
topology, that the metabolic model closely resembles the cell type and experimental condition 
one wants to investigate, e.g., oxygen needs to be restricted to investigate hypoxia. The 
exchanges are best defined based on the experimental condition that one aims to model, e.g., 
culture medium composition, substrate and oxygen uptake rates. In absence of matching 
experimental data, literature values may substitute missing information [7, 47], but it should 
be noted that they can vary substantially between experimental setups and hence, may affect 
the prediction accuracy of the condition-specific model.  
 
The function setMediumConstraints allows the definition of the model constraints and provides 
options for various configurations. If the composition of the cell culture medium is defined, the 
metabolite concentrations can be converted into fluxes that define metabolite uptake in the 
model using the function setMediumConstraints (Figure 3B). For this, cell number, cell dry 
weight (supplemental material), and experiment duration need to be known. The rationale of 
the added constraints is to restrict the model’s metabolite uptake flux to the amount that was 
available to one cell and per 1 hour of the experiment. The medium composition can thus be 
used to reproduce in silico the experimental, or cell-type specific, condition (Figure 3B). 
 
The model requires certain inputs and outputs to have a non-zero value for an objective 
function. For example, for the production of biomass of a human cell, the uptake of essential 
amino acids, ions, and other compounds needs to be provided to the model to render the 
objective function feasible (i.e., non-zero; see Box 1). Essential uptake reactions can be 
identified, e.g., using flux variability analysis (see Box 1).  
 
The function setMediumConstraints includes an option to change the infinite bound (which is 
often defined as -1000 U for reverse reaction flux and +1000 U for the forward reaction flux), 
if it is necessary to prevent that the model is artificially constrained by imposed “infinite” 
bounds (see Step 16B). If the growth rate, or doubling time, for the given experiment is 
6 
 
available, it can be set as constraint on the biomass reaction using the function 
setMediumConstraints or changeRxnBounds.  
 
Integration of metabolomic data (Step 6-13): Metabolomic data can be integrated with 
metabolic models by enforcing exchange rates to uptake or secrete in accordance with the 
experimental data (Figure 3B-C). To enforce the respective directionality, minimal flux values 
for uptake and secretion should be defined, e.g., by using information on the detection limit for 
each metabolite (Figure 4). The underlying rationale is that as the metabolite has been measured 
at a higher or lower level after a certain time and hence, the secretion/uptake had to be above 
the corresponding detection limit. The conversion of the limits of detection from ng/ml to mM 
can be done using the function calculateLODs and using the molecular weight of the 
metabolites (see supplemental material). Uptake and secretion profiles for each sample are 
generated from an input data matrix using the function defineUptakeSecretionProfiles. See 
supplemental tutorial I for an example of the input data matrix. The directionality of exchange 
is defined based on the change over time in the spent medium and with respect to the change 
in the controls to rule out effects of spontaneous metabolite degradation (Figure 5A-B). The 
direction of the exchange might change when the controls are taken into consideration because 
the signal might drop over time in these medium controls, whereas it seems to remain stable in 
the cell culture medium due to secretion of the cells. Such cases need to be looked at carefully 
and it might be worth to exclude those data points. Mass spectrometric measurements are not 
exact and generally associated with an error. The calculated change between control and 
sample is also highly sensitive to the SD. A calculated net change of 5% can be meaningless if 
the SD is 10%. Hence, caution should be taken when incorporating changes in metabolite 
abundance, when the change is below or close to the SD. The tutorials illustrate how the 
constraints can be adjusted to one’s data set at the different parts of the workflow.  
 
The uptake and secretion profiles are combined with the detection limits using the function 
calculateQuantitativeDiffs and integrated with the model using the function 
setQualitativeConstraints. As a consequence, the flux through an exchange reaction must lay 
between the smallest detectable and the highest possible flux in case of uptake (defined by the 
medium composition), and between the minimal detectable efflux and the ‘infinite’ flux value 
for secreted metabolites (Figure 4).  
 
In an additional step, relative differences in metabolite uptake and secretion can be integrated 
to compare pairs of models (Figure 4, 5C). The relative differences are defined using the 
function calculateQuantitativeDiffs based on the comparison of change between the samples 
and with respect to the controls (slope ratio, Figure 5A). Subsequently, the quantitative 
differences are applied to the two models (Figure 3, 5A, C) using the function 
setSemiQuantConstraints. 
 
If absolute concentrations have been obtained for at least two time points, they can be converted 
into fluxes using the function conc2rate and applied as bounds on the exchange reactions 
considering a user-defined error (Figure 4). Individual uptake and secretion profiles are 
produced from an input data matrix of flux values with samples (columns) and metabolites 
(rows) using the function prepIntegrationQuant (see tutorial II). Negative values will be 
interpreted as uptake and positive values are interpreted as secretion. Based on the input model 
and user-defined minimal and maximal values, the function prepIntegrationQuant tests 
whether the uptake and/or secretion of each individual exchange in the input data matrix is 
feasible, using flux balance analysis [30]. If a metabolite cannot be consumed or secreted by 
the model due to missing synthesis or degradation pathways, these metabolite exchanges will 
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be removed automatically from the exchange profiles. If only the secretion is infeasible, the 
secretion value is eliminated from the profiles, whereas the uptake value of the same metabolite 
will be kept. The function checkExchangeProfiles can be used to generate statistics on the 
number and identity of uptake and secretions added per sample. 
 
After individual uptake and secretion profiles have been generated for each sample, i.e., cell 
types or conditions, these can be integrated with the metabolic model using the function 
setQuantConstraints. The function setQuantConstraints offers the option to add or eliminate 
constraints, e.g., if quantities or combination of constraints render the model infeasible. The 
function also allows the user to specify a lower bound for the objective function, which ensures 
that the output model is able to grow or to perform a specified metabolic task (e.g., lactate 
production), while the upper bound remains unconstrained. Which objective function is chosen 
should be carefully decided based on the experimental context (see [48] for discussion on use 
of different biomass objective functions for human cells). The output of setQuantConstraints 
is a contextualized submodel for each sample. The integration of quantitative extracellular 
metabolomics data can be performed for large sample collections [32].   
 
Generation of contextualized metabolic models (Step 14): The function 
setQuantConstraints automatically generates a contextualized model for each sample by 
calling the function generateCompactExchModel. These contextualized models are based on a 
minimization of the cardinality of exchange reactions of the constrained model, which means 
that the number of exchanges, in addition to those defined by constraints (e.g., metabolomic 
data), is minimized in the resulting model [32]. As the function generateCompactExchModel 
relies on an approximation, which may not be minimal [32], the minimization is repeated until 
the number of added exchange reactions cannot be further reduced. Additional exchanges may 
be required as untargeted metabolomics methods can still not measure and identify the entire 
metabolome, despite continuous improvements in the field [49]. In contrast, targeted 
metabolomics methods measure only a defined subset of a given metabolome, and thus, more 
metabolites may be exchanged with the environment by the cell. Our computational approach 
was set up to deal with these technical limitations by adding the required minimal set of 
metabolites that would together with the defined uptake and secretion profile, explain the 
measured differences in the cell phenotypes [32].  
 
After the minimal set of required exchanges is defined, blocked (i.e., flux inconsistent) 
reactions are identified [26] and a flux-consistent submodel (‘pruned’) is extracted. The pruned 
model contains the predicted minimal set of exchange reactions (including constraints based 
on the quantitative data) as well as an active set of internal reactions. The constrained pruned 
and the constrained unpruned model are returned from the function setQuantConstraints as a 
structure variable ResultsAllCellLines. Additionally, an overview table is returned 
(OverViewResults), which summarizes the numbers of reactions, metabolites, and genes for 
each contextualized model of the sample set. The information in these variables are extended 
by the downstream analysis functions (see Step 17).  
 
Note that the function generateCompactExchModel only returns one of multiple alternative 
solutions. The relevance of the set of metabolite exchanges added to the model needs to be 
evaluated, e.g., by comparison with the carbon sources commonly used by the cell type or 
organism based on experimental data [32]. The function generateCompactExchModel can also 
be applied to generate a contextualized model after qualitative or semi-quantitative constraints 
have been applied.  
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The function extractConditionSpecificModel has previously been used to extract a flux 
consistent model in [7]. The ‘minimal’ set of exchanges identified through this function is also 
not unique and the number and chosen additional exchange reactions depended on the order, 
in which the tested exchange reactions were closed.  
 
Multi-omics integration (Step 15): MetaboTools supports the integration of gene expression 
and proteomic data. The function integrateGeneExpressionData can be applied to qualitatively 
integrate transcriptomic or proteomic data along with the metabolomic data. The function 
disables reactions (i.e., it sets the lower and upper bound to 0) associated with the user-defined 
set of unexpressed genes. This stringent treatment may lead to an infeasible model, if any 
metabolite required for the objective cannot be produced anymore by the model. The manual 
assessment and curation of gene expression data integration has been previously described for 
a signaling model [33]. The same principles apply to a metabolic network. A multitude of other 
methods exists for the integration of transcriptomic data [24]. Whether to curate an infeasible 
model based on literature or to use a different approach for gene expression data integration 
(e.g., createTissueSpecificModel as implemented in the COBRA toolbox [29]) needs to be 
determined for each case.  
 
Proteomic data can be integrated in a similar way as transcriptomic data. In this case, the protein 
identifiers need to be matched to the gene IDs in a model, whereby the same attention should 
be paid to the conversion of protein to gene IDs as for the association of metabolite IDs to the 
model metabolites. Subsequently, the set of gene IDs that is associated with the absent proteins 
constitutes the input for integrateGeneExpressionData. It is recommended to treat missing 
gene/protein data points as present rather than absent. The additional omics constraints can be 
applied either before integrating metabolomic data, after executing setMediumConstraints, or 
after generating the contextualized models (i.e., after executing either setQuantConstraints or 
generateCompactExchModel). 
 
Stage 3 - Model validation and prediction of phenotypes 
 
Assessment of constraints and expectations (Step 16): The workflow supported by 
MetaboTools allows rapid generation of contextualized models. Yet, during optimization, a 
minimal set of exchanges, consistent with the provided experimental data, will be chosen 
without consideration of the biology. Furthermore, the complexity and redundancy of the 
metabolic network allows the prediction of submodels and results that comply with the applied 
set of constraints and the biologically well informed network topology, but which may not be 
necessarily biologically meaningful. For instance, cellular processes, such as signaling and 
regulation, influence metabolism and might prevent possible functional states in vivo or in vitro 
but they are not included in the model. Thus, the applied constraints and predicted exchanges 
need to be manually evaluated against the biological knowledge before proceeding with further 
computational analysis. If falling below the error range or exceeding the infinite bounds, 
constraints might need to be scaled (see supplemental material). All added exchanges and 
directions of exchange should be controlled to identify missing or erroneous  constraints. For 
example, in our previous study, the initially generated set of cancer models predicted 
consumption of superoxide and secretion of oxygen because the constraints had not been 
appropriately defined [32]. The example illustrates the importance of manual inspection and 
biological insight when generating condition-specific models from experimental data (Table 
2). Table 3 lists questions to ask and data to consider during this initial validation of the 
contextualized models.  
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The ability of the contextualized models to grow at the same rate as in the experiment can also 
be used to validate the contextualized model [32]. The optimization of biomass can be applied 
to cells in the exponential growth phase, and optimizing for biomass assumes that the cells are 
thriving towards optimal biomass production (see for explanation on the biomass composition 
[43]). However, growth might not be the suitable when dealing with primary human cells, 
where alternative biomass reactions, e.g., for maintenance of cells, may be assumed [48]. If 
doubling times are available for the experiment, the function 
setConstraintsOnBiomassReaction can be used to incorporate constraints on the biomass 
reaction, while considering a user-defined measurement error (e.g., ±20%) to separate upper 
and lower bound. Even slight differences in the culture conditions may have an impact on the 
growth performance of the cells.  
 
MetaboTools contains a set of functions to investigate different aspects of the metabolic model 
(Step 24A-F), particularly when generating multiple models from a large sample set. The 
choice of the analysis to be conducted depends on the biological question to be addressed. Prior 
knowledge of pathways to focus the analysis on will prevent getting overwhelmed by the 
amount of output data, and will help to identify inaccuracies in the model(s) before dedicating 
too much time on the analysis (Table 2). To facilitate the interpretation especially for large 
model sets, MetaboTools contains functions that organize the analysis output into statistics and 
digestible tables [32].  
 
Define essential genes across a set of contextualized models (Step 17A): The function 
analyzeSingleGeneDeletion predicts and summarizes essential genes of one or multiple models 
(Figure 6). The function returns the number of essential genes per model and a table, which 
sorts all genes that appear in one or more models into the three categories: ‘no effect’, ‘all KO’, 
and ‘partial effect’ along with the frequency of each effect among the tested set of models. 
Based on this table, interesting essential genes can be identified, e.g., those affecting only a 
subset of models, or all models equally (Table 4). The results for the individual model are 
added to the *ResultsAllCellLines* structure. 
 
Identify essential reactions (Step 17B): A gene being essential for a model means that one or 
more reactions (i.e., combinations of reactions), which are associated with this gene, need to 
carry flux in the model in order to satisfy the defined objective function. However, the reactions 
associated with a gene can be distributed across different pathways, and depending on the 
pathway, the reaction may be more or less interesting for a biological question. E.g., an 
antimetabolite designed to target a non-essential reaction is useless because it would not stop 
a cell from proliferating. Hence, the function checkEffectRxnKO identifys the subset of  
essential reactions that are associated with a specified set of (essential) genes.  
 
Investigate common and distinctive features of a set of models (Step 17C): Common and 
distinctive features between condition specific models can be insightful, e.g., to build a generic 
tissue model from a set of context specific tissue models. The function makeSummaryModels 
generates both, a union model and an intersect model, which sum either the common or the 
superset of reaction, metabolites and genes of a set of contextualized models.  
 
Analyze flux splits (Step 17D): Cells use different pathways to produce energy and other 
crucial metabolites [32]. The function predictFluxSplits predicts how a metabolite of interest 
(e.g., ATP) is produced or consumed by the different reactions in the models (Figure 7). The 
analysis is based on a flux vector generated by using parsimonious flux balance analysis [50]. 
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The function predictFluxSplits can also be used to predict a ‘metabolite yield’, i.e., the sum of 
flux producing a metabolite (e.g., ATP) divided by the uptake flux of a user-defined carbon-
source, e.g., glucose exchange. Because no additional constraints are applied for this analysis, 
the, e.g., ATP generated by the model will not only be produced from glucose but also other 
substrates available to the model depending on the constraints on the exchange reactions of the 
individual model. Nevertheless, the metabolite yield constitutes a valuable measure to stratify 
metabolic models [32].   
 
The results generated by predictFluxSplits can be summarized using the function 
sumFluxSplits, which provides a table listing for each model the reaction that produces the 
highest amount of the metabolite (highest flux among the reactions producing/consuming the 
metabolite of interest). Another output table provides the flux values to allow a comparison of 
the metabolite producing reactions across the model set. Based on the different strategies of 
how models produce or consume different relevant metabolites, sets of models can be divided 
into phenotypes [32] . 
 
 
Sampling the solution space (Step 17E): Sampling is a method to explore the metabolic 
phenotype of a contextualized model without relying on an objective function [47, 51]; and 
hence, it is particularly suitable for modeling of human cells and biomedical applications [48]. 
The function performSampling performs the sampling analysis, including a priori generation 
of warm-up points using the functions of the COBRA toolbox [29]. After a specified number 
of flux vectors (sampling points) has been collected from the solution space of the model, the 
result of the analysis is illustrated as the probability distribution of flux for individual reactions 
in the model [51, 52] (supplemental material). The function summarizeSamplingResults obtains 
statistics on the sampling points and for each reaction (mean, median, and minimal and 
maximum flux values determined through flux variability analysis). It also generates 
histograms of the probability distributions for a set of user-defined reactions (Figure 8). 
Distinct use of pathways or reactions (e.g., directionality) can be directly observed from the 
histograms [4, 7, 47].  
 
Predict response to environmental changes (Step 17F): Contextualized models can react 
differently to perturbations of the existing constraints [32]. The function performPPP can be 
used to analyze the impact of stepwise variations of flux forced through two exchange 
reactions. The “behavior” of the model is equal to the model being able to satisfy the stated 
objective. In other words, a flux balance analysis is performed at each step of the analysis, 
which means after the constraints of one of the two exchange reactions have been modulated. 
The variations can be either uptake or secretion, and the direction can differ between the two 
exchange reactions. This analysis was used to test the models response to variations in oxygen 
uptake and lactate secretion [32]. The results of the analysis can be illustrated as a heat-map 
using the function illustrate_ppp. The size and the shape of the feasible solution space within 
the heat map was used to manually distinguish different phenotypes among the set of 
contextualized models [32].  
 
Validation of the model predictions (Step 18): The predicted set of essential genes 
(analyzeSingleGeneDeletion), preferential pathway use (predictFluxSplits), and feasible 
uptake rates (performPPP), constitute hypotheses and need to be validated. The validation of 
model predictions is an indispensable part of the computational workflow. In many studies the 
results are experimentally validated to substantiate the computational results [7, 14, 22, 23, 53, 
54]. Others relate the model predictions to the analysis of omics data sets from cell cultures or 
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patients [55, 56]. In case model predictions cannot be experimentally validated, model 
predictions should be supported by literature evidences [57, 58]. As many results as possible 
should be validated, but at least all main results of the study. The validation of the model 
prediction completes the workflow for the integration of extracellular metabolomic data and 
phenotype prediction.  
 
3. Materials 
 
3.1 Equipment  
  Hardware 
o Personal computer  
 
Software 
o Matlab (Mathworks, Inc.) 
o COBRA Toolbox v2.0 & MetaboTools 
o fastFVA 
(http://wwwen.uni.lu/lcsb/research/mol_systems_physiology/software) 
o A linear programming solver. We recommend the industrial quality solver 
cplex (IBM Inc.) as it can be used under a free academic license. Note that 
generateCompactExchModel requires cplex (IBM Inc.) to be installed and 
called from Matlab. 
o Obtain model (e.g., download the most recent version of the human 
metabolic genome scale model and numerous gut microbe metabolic 
models from the virtual metabolic human database (VMH, 
https://vmh.uni.lu/). 
 
Knowledge  
o Knowledge on the use of COBRA toolbox 
o Knowledge on the use of matlab 
 
Additional training in COBRA can be acquired from  
o Detailed description on the installation of the COBRA toolbox v2.0, are 
provided in a previous protocol on the COBRA toolbox [29].  
o Consider the COBRA toolbox forum for help 
(https://groups.google.com/forum/#!forum/cobra-toolbox). 
o FBA primer supplemental tutorial [30] 
 
 
3.2 Equipment setup 
o Install Matlab 
o Download COBRA toolbox (incuding MetaboTools) from 
(https://github.com/opencobra/cobratoolbox) and add to Matlab path 
Hint: Specifically, follow procedure steps 1-4 of the COBRA toolbox 
protocol [29] to ensure a functional COBRA toolbox. Functions that are not 
further explained in this protocol are part of the COBRA toolbox and their 
use has been described in detail in the COBRA toolbox protocol [29]. 
o Install solver 
o Obtain a metabolic model (e.g., https://vmh.uni.lu/) 
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3.3 Input data when integrating metabolomic data 
 Mandatory input data Extracellular metabolomic data (minimum two 
time points to calculate fluxes, see tutorials for format requirements) 
 For conversion of metabolomic data to fluxes: cell weight, cell 
concentration\ml, duration of the experiment  
 Information about medium composition 
 Serum in medium (yes/no). 
 Detection limits of the measured molecules 
 
3.4 Optional input data 
 Growth curves/ doubling times (hrs.) 
 Transcriptomic or proteomic data (A/P calls) 
 Additional measurements (e.g., oxygen consumption, CO2) 
 
 
 
4. Procedure:  
Stage 1:  Preparations for the integration of the data (Steps 1-5) 
1) Associate metabolite identifiers with metabolite IDs, Trouble Shooting 
Manually relate the metabolite identifiers in the metabolomic data to the 
corresponding metabolite abbreviation in the model (Figure 2A). If no HMDB [41] 
or corresponding IDs exist, associate the metabolites based on the metabolite name 
using metabolite databases. Find the exact matches.  
 
2) Identify metabolites that have no transport or exchange reaction, Trouble 
Shooting 
Compile a list and check off metabolites that have transport reactions (e.g., gln_L[e] 
<=> gln_L[c]) and exchange reactions (‘EX_gln_L(e)’) in the model. This can be 
done manually using the VMH database (https://vmh.uni.lu/, Figure 2B) or the 
models reaction list:  
 
Alternatively use the function findRxnsFromMets to generate a list of reactions 
(*rxnList*) that are associated with the list of successfully associated metabolites 
(*metList*): 
 
>> [rxnList, rxnFormulaList] = findRxnsFromMets(model, metList) 
 
Check also the lower and upper bounds of the transport and exchange reactions to 
confirm that the directionality corresponds to the reaction formula.  
 
To print the reaction list use:  
>> a = printRxnFormula(model, rxnList,0,0,0,'',0);  
 
Note that the reversibility vector (*model.rev*) is not updated by all functions in the 
COBRA toolbox. Most functions rely on the definition of the lower and upper bounds 
rather than the reversibility vector. Use the following code to make the reversibility 
vector consistent with the lower and upper bounds: 
 
>> model.rev = zeros(length(model.rxns)); 
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>> model.rev(find(model.lb<0)) = 1;  
 
3) Identify metabolite transporter 
Manually identify and define as detailed as possible the extracellular metabolite 
transport systems for all associated metabolites lacking extracellular transport 
reactions based on the relevant literature (Figure 2C) [43, 59].  Start, e.g., by typing 
“metabolite AND transport” into a search engine or the NCBI PubMed database 
(http://www.ncbi.nlm.nih.gov/pubmed/). Variations of the key words will provide 
you with a first impression on the amount of literature that exists on the transport 
systems of individual metabolites. Transporters vary between compartments. Hence, 
specifically identify extracellular transport systems. Check for organism, tissue- and 
cell-type specific metabolite transport mechanisms. Does the literature describe or 
indicate active or passive transport (primary transport, secondary transport, or simple 
diffusion)? Identify additional substrates and co-substrates (such as ions, energy 
currency, or other metabolites), as well as the direction of transport (antiport versus 
symport). What is the reaction stoichiometry of the transported compounds? Identify 
the genes that encode the transport proteins. Consider the existence of isoforms and 
multiple subunits of protein complexes. Keep track of references to all aspects of the 
transport. Take notes on contradictory information to enable yourself or others to 
recapitulate decisions at a later stage. Identify all existing transport mechanisms. 
Keep the number of diffusion reactions as low as possible by resolving as many 
transport mechanisms and as detailed as possible. When using information from 
databases, confirm the correctness of the information based on the primary literature, 
e.g., confirm that it is extracellular transport and appears in your cell or organism. 
 
4) Add reactions 
Reconstruct the transport reactions based on your notes and add them to the model 
using rBioNet [46] in Matlab. Add missing exchange reactions using rBioNet [46].  
 
Stage 2:  Set constraints and derive contextualized models 
 
5) Define basic constraints, Trouble Shooting 
Use the function setMediumConstraints to impose the condition-specific sets of 
constraints to a model (*model*). When data values exceed the infinite bounds, 
increase the current bounds (*current_inf*) such that the infinite bounds no longer act 
as constraints (*set_inf*). Based on cell concentration (*cellConc*), the duration (*t*) 
of the cultivation, and the cell dry weight (*cellWeight*) fluxes are calculated from 
metabolite concentrations given in mM (*met_Conc_mM*) for a defined set of 
metabolites exchange reactions (*medium_composition*), which were part of the 
defined cell culture medium, and the model is constrained with these fluxes. Uptake of 
additional compounds, e.g., ions or vitamins can be restricted (*mediumCompounds*, 
*mediumCompounds_lb*). The optional input variable *customizedConstraints* 
allows individual definition of additional reaction constraints, e.g., growth rates.  
 
>> [modelMedium, basisMedium] = setMediumConstraints(model, set_inf, 
current_inf, medium_composition, met_Conc_mM, cellConc, t, cellWeight, 
mediumCompounds, mediumCompounds_lb, [customizedConstraints], 
[customizedConstraints_ub], [customizedConstraints_lb], [close_exchanges]) 
 
6) Transform the LOD from ng/ml to mM 
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Use the molecular weight (*theo_mass*) of the metabolites and the respective exchange 
reaction for the metabolites (*ex_RXNS*) to transform the LOD from ng/ml 
(*lod_ngmL*) to mM (*lod_mM*).  
 
>> [LODmM] = calculateLODs(ex_RXNS, theo_MASS, LODngmL); 
 
7) Define uptake and secretion profiles (no absolute quantification) 
Define sets of metabolites that are consumed (*cond1_uptake* and *cond2_uptake*) 
and released (*cond1_secretion* and *cond2_secretion*) based on the individual data 
matrices (*input_A* and *input_B*) and the corresponding exchange reactions 
(*data_RXNS*) using the function defineUptakeSecretionProfiles for sample pairs. 
Manually define the threshold (*tol*) to accept a change as uptake or secretion. The 
function contains further options to manually tailor the uptake (*exclude_upt*, 
*add_upt*) and secretion profiles (*exclude_secr*, *add_secr*). 
 
>> [cond1_uptake, cond2_uptake, cond1_secretion, cond2_secretion, slope_Ratio, 
data_RXNS] = defineUptakeSecretionProfiles(input_A, input_B, data_RXNS, tol, 
essAA_excl, exclude_upt, exclude_secr, add_secr, add_upt); 
 
8) Calculate semi-quantitative differences 
Use the function calculateQuantitativeDiffs to add the LODs to the uptake and secretion 
profiles and to obtain the values for the relative adjustment of constraints 
(*cond1_upt_higher*, *cond2_upt_higher*, *cond2_secr_higher*, 
*cond1_secr_higher*) based on the *slope_Ratio* of the commonly consumed and 
released metabolites (Figure 5A). Additional inputs are the uptake and secretion 
profiles generated in the previous steps by the functions defineUptakeSecretionProfiles 
and calculateLODs. The input *LODmM* is of the same length as the vector specifying 
the exchange reactions *ex_RXNS*.  
 
>> [cond1_upt_higher, cond2_upt_higher, cond2_secr_higher, cond1_secr_higher, 
cond1_uptake_LODs, cond2_uptake_LODs, cond1_secretion_LODs, 
cond2_secretion_LODs] = calculateQuantitativeDiffs(data_RXNS, slope_Ratio, 
ex_RXNS, lod_mM, cond1_uptake, cond2_uptake, cond1_secretion, 
cond2_secretion); 
 
9) Set qualitative constraints 
Use the function setQualitativeConstraints to apply individual uptake (*cond_uptake*) 
and secretion (*cond_secretion*) profile to a model by using the detection limits to 
enforce uptakes and secretions (*cond1_uptake_LODs*, *cond2_uptake_LODs*, 
*cond1_secretion_LODs*, *cond2_secretion_LODs*). Execute this function for each 
model individually: 
 
>> [modelLOD] = setQualitativeConstraints(model, cond_uptake, 
cond_uptake_LODs, cond_secretion, cond_secretion_LODs, cellConc, t, cellWeight, 
ambiguous_metabolites, basisMedium); 
  
Use the input variable *ambiguous_metabolites* to keep exchanges open and let the 
model freely consume or release the associated metabolites, e.g., if direction of 
exchange is undefined or differs between biological replicates. All lower bounds of 
exchange reactions, apart from those defined as ambiguous, mediumCompounds or 
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from the uptake and secretion profiles, will be constrained to zero. The output model 
*modelLOD* has the same size of the input model. 
 
10)  Apply semi-quantitative differences 
Use the function setSemiQuantConstraints to apply the semi-quantitative differences to 
two models *modelA* and *modelB*, which were previously defined by the function 
calculateQuantitativeDiffs (*cond1_upt_higher*, *cond2_upt_higher*, 
*cond2_secr_higher*, *cond1_secr_higher*). This step is performed simultaneously 
for the two models. 
 
>> [modelA_QUANT,modelB_QUANT] = setSemiQuantConstraints(modelA, 
modelB, cond1_upt_higher, cond2_upt_higher, cond2_secr_higher, 
cond1_secr_higher); 
   
11)  Obtain uptake and secretion profiles [integration of absolute concentration 
changes], Trouble Shooting 
Use the function prepIntegrationQuant to generate individual uptake and secretion 
profiles from a data matrix (*metData*) of fluxes, where the rows are the metabolite 
exchanges (*exchanges*) and the columns are the conditions (*samples*). Negative 
values are interpreted as uptake and positive values are interpreted as secretion. The 
individual exchange profile is saved to the user-defined location (*path*). The minimal 
and maximal flux values (*test_max*, *test_min*) are used to test whether the *model* 
can consume and secrete the *exchanges*. All fluxes below a user-defined tolerance 
value (*tol*) are set to zero. The output consists of the flux values to be applied to the 
upper and lower bounds, which are based user-defined variation (of, e.g., 20%, 
*variation*) for uptake and secretion, and written to a file named according to the same 
name to the specified location. 
 
>> prepIntegrationQuant(model, metData, exchanges, samples, test_max, test_min, 
path, tol, variation);  
 
12)  Check the exchange profiles  
Check if additional metabolites have been removed from the uptake and secretion 
profiles. Use the function checkExchangeProfiles to generate statistics on the number 
and identity (*mapped_exchanges*, *mapped_uptake*, and *mapped_secretion*) of 
uptake and secretions added per sample (*minMax*). Specify the number of 
metabolites in the data set (*nmets*). The function loads the exchange profiles 
generated by using the definition of the *path* and the sample names (*samples*).  
 
>> [mapped_exchanges, minMax, mapped_uptake, mapped_secretion] = 
checkExchangeProfiles(samples, path, nmets); 
 
13)  Integrate quantitative constraints, Trouble Shooting 
Use the function setQuantConstraints to generate a contextualized model 
(*ResultsAllCellLines.sample.modelPruned*) for each sample (*samples*). A 
minimal flux value (*minGrowth*) can be specified for a defined objective function 
(*obj*). A set of metabolite exchanges (*medium*) can be specified, which will be 
part of the retained minimal set of exchange reactions in the output model. Allow 
additional secretion of metabolites (*addExtraExch*, *addExtraExch_value*). The 
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exchange profile is loaded from the specified location (*path*). The default value of 
epsilon is 1e-4, see [26] for a detailed description.  
 
>> [ResultsAllCellLines,OverViewResults] = setQuantConstraints(model, samples, 
tol, minGrowth, obj, no_secretion, no_uptake, medium, addExtraExch, 
addExtraExch_value, path, [epsilon]); 
 
The output structure *ResultsAllCellLines* contains the pruned and unpruned but 
constrained contextualized model for each sample (*samples*). *OverViewResults* 
is a table which lists statistics of the generated models. 
 
14)  Generate the contextualized subnetworks 
 
A) Use generateCompactExchModel to generate a submodel. This pruned model is  
based on the prediction of a minimal set of metabolite exchanges for a given, 
constrained model, e.g., the model resulting from running setQualitativeConstraints 
or setSemiQuantConstraints, while permitting a feasible steady state flux 
distribution. The prediction of the additional metabolite exchanges is based on the 
minimization if the cardinality of the exchange reactions [32]. Define the minimal 
flux value (*minGrowth*) that should be achieved by a defined objective 
(*biomassRxn*) in the output model (*modelMin*, *modelPruned*). The use of 
fast flux variability analysis [60] (*fastFVA*) is optional. 
 
>> [modelMin, modelPruned, Ex_Rxns] = generateCompactExchModel(model, 
minGrowth, biomassRxn, prune, fastFVA); 
 
B) Alternatively, use extractConditionSpecificModel to extract the submodel using the 
approach as in [7]. Specify the cutoff (*theshold*) for calling a flux value zero (e.g., 
1e-8).   
 
>> [modelPruned] = extractConditionSpecificModel(model, theshold); 
 
15)  Integrate gene expression data 
Use the function integrateGeneExpressionData to integrate transcriptomic data (set 
of genes found to be unexpressed (*dataGenes*)) with the *model*.  
 
>> [modelGE] = integrateGeneExpressionData(model, dataGenes); 
  
Stage 3:  Validation and prediction 
 
16) Validation of the model, Trouble Shooting 
Perform a quality control of the models by checking constraints against biological 
insight. The steps 16E-F can only be performed if the data exists. 
 
A) Create an expectation  
If not done already, review the literature to learn about the biological background 
of your cells, organisms, and what to expect from the analysis: Identify metabolic 
traits and inabilities of the target cell and what is known about the respective set of 
environmental conditions and its response to perturbations. Validate the generated 
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models based on these biological insights, e.g., by asking questions such as those 
given in Table 3. 
 
B) Check constraints, Trouble Shooting 
Check lower and upper reaction bounds in the generated models. Check that all 
constraints have been applied as intended, e.g., typos in the exchange reaction 
names might have prevented that constraints were applied. Are all exchange 
reaction constrained to zero that should have been closed? Do constraints exceed 
the infinite bounds? Are any constraints below the threshold and thus equal to zero? 
Are there any constraints that do not concur with the expectation, e.g., uptake of 
oxygen? 
 
C) Analyze added exchanges, Trouble Shooting 
Summarize the set of added exchanges using the functions 
statisticsAddedExchanges and mkTableOfAddedExchanges:  
 
>> [Ex_added_all_unique] = statisticsAddedExchanges(ResultsAllCellLines, 
samples); 
 
>> [Added_all] = mkTableOfAddedExchanges(ResultsAllCellLines, samples, 
Ex_added_all_unique); 
 
Check the additional exchanges that were added to the model. Are the metabolites 
predicted to be consumed part of the medium composition? Was serum added to 
the culture medium? For all metabolites, which the model needs to secrete, could 
these metabolites have been detected? Were they targeted by the metabolomic 
analysis? Could they have been below the limit of detection? Does untargeted 
metabolomic data support the presence of these metabolites in the extracellular 
medium? 
 
D) Check metabolic functions, Trouble Shooting 
After confirming that the constraints are accurately set, check the functionality of 
the model against the expectation build earlier. Does the model include metabolic 
pathways known to be operated by the cell and in the considered condition? Which 
pathways are in the model that are not expected to be present in the modeled cell 
type? Keep in mind that the model was optimized to explain the uptake and 
secretion profile and that the internal reaction redundancy remains, if no additional 
omics data is included. Check, using flux variability analysis, if the unexpected 
pathways have to carry flux. What imposed exchanges are responsible for the flux 
through such a pathway?  
 
E) Validate the contextualized model based on experimental data  
Use, e.g., intracellular metabolomic data. Check to which extend metabolites 
reported in intracellular metabolomic data are captured by the contextualized model 
(i.e., are the metabolites part of model.mets). Do the models reflect sample-specific 
differences?  
 
F) Test for condition-specific growth rates 
If growth rates were not applied as constraints during the model building, use the 
function setConstraintsOnBiomassReaction to apply constraints to the biomass 
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reaction based on doubling times (*dT*). The upper and lower bounds of the 
biomass objective function (*of*) are adjusted with a *tolerance* around the 
calculated growth rate (e.g., 10 %). 
 
>> [modelBM] = setConstraintsOnBiomassReaction(model, of, dT, tolerance); 
 
Alternatively, use the function changeRxnBounds to apply growth rates to the 
model. Make sure the objective is set in the model (use the function 
changeObjective to change the objective in the model). 
 
If no doubling times or growth rates exist for the data set, literature derived rates 
can provide an approximation for the expected growth rates, as growth rates can 
vary depending on the culture conditions (e.g., serum or no serum). Use flux balance 
analysis (optimizeCbModel) to see if the model can produce biomass at 
experimental rates. 
 
17)  Predict metabolic phenotypes, Trouble Shooting 
Choose the most suitable analysis (e.g., 17A-E) based on the individual biological 
question to gain insight into the use of the most relevant pathways, reactions, or 
metabolites by individual or groups of models. 
 
A) Summarize and illustrate the set of essential genes 
Use the function analyzeSingleGeneDeletion to define and to analyze the set of 
essential genes for single or large set of models (*ResultsAllCellLines*, 
*samples*). Define through the input variable *heat* if a heat map should be 
generated, illustrating the differences across the model set (Figure 6). Save the 
output at the specified location (*path*). 
 
>> [genes,ResultsAllCellLines,OverViewResults] = analyzeSingleGeneDeletion 
(ResultsAllCellLines, path, samples, cutoff, OverViewResults); 
 
The output variable *genes* contains a table that lists per unique gene the number 
of models with 'no effect', 'partial effect', essential genes or 'KO', and in how many 
models the gene is not present. Additionally, the number of essential genes is added 
to *OverViewResults* and the output of the single gene deletion is added to 
*ResultsAllCellLines*. 
 
B) Identify the essential reactions driving gene essentiality, Trouble Shooting 
Use the function checkEffectRxnKO to identify, which reactions are essential. 
Provide the set or subset of models (*samples_to_test*) from *samples* that should 
be tested. The functions tests all individual reactions associated with a set of 
specified genes (*genes_to_test*). The variable *fill* defines what to add into the 
output matrix if a reaction is not in the model, e.g., 100, num('NAN')). 
 
>> [FBA_Rxns_KO, ListResults] = checkEffectRxnKO(samples_to_test, fill, 
Genes_to_test, samples, ResultsAllCellLines); 
 
The output variable *FBA_Rxns_KO* contains the FBA results for constraining 
one reaction at a time to zero. The second output *ListResults* lists the reactions 
associated with the input gene list in the same order as *FBA_Rxns_KO*. 
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C) Generate intersect and union model 
Use the function makeSummaryModels to find the shared and superset of reactions, 
metabolites and genes of a set of models by creating a union (*unionModel*) and 
an intersect model (*intersectModel*). The models are generated based on the 
generic model (*model*) from which the subnetworks have been generated.  
 
>>  [unionModel, intersectModel, diffRxns, diffExRxns] = 
makeSummaryModels(ResultsAllCellLines, samples, model, mk_union, 
mk_intersect, mk_reactionDiff); 
 
Both output models (*unionModel*, *intersectModel*) and differential reaction 
sets (*diffRxns*, *diffExRxns*) are generated by default. 
 
D) Predict flux splits 
Use the function predictFluxSplits to predict either production or consumption 
(*dir*) of metabolites (e.g., *met2test* = {‘atp’}) for the models in 
*ResultsAllCellLines* defined by *samples*. Define the objective function (*obj*) 
that should be used to generate the flux vector, from which the reaction 
contributions to production or consumption of the considered metabolite are 
calculated. Define a full sized model (*model*), as the set of models can use distinct 
subsets of the reactions of the full model to produce or consume the metabolite of 
interest. A default value (eucNorm = 1e-5) is set for the parsimonious flux balance 
analysis. Set a quadratic programming solver (changeCobraSolver(solver,‘QP’)) 
before running predictFluxSplits. 
 
>>  [BMall, ResultsAllCellLines, metRsall, maximum_contributing_rxn, 
maximum_contributing_flux, ATPyield] = predictFluxSplits(model, obj, met2test, 
samples, ResultsAllCellLines, dir, transportRxns, ATPprod, carbon_source, 
eucNorm); 
 
Exclude reactions, which do not produce or consume the metabolite, e.g., reactions 
that transport the metabolite between compartments. Define all reactions that 
produce/consume the metabolite in a first run (*transportRxns* = []), and 
subsequently, exclude unwanted contributors by adding them to *transportRxns*.  
 
In case that the production of ATP is predicted, additional statistics on the use of 
glycolysis, the citric acid cycle, and the oxidative phosphorylation can be 
automatically generated (*ATPprod*=1). With this option, the *ATPyield* is 
calculated, which relates the total ATP production to a user-defined carbon source 
(default: *carbon_source* = 'EX_glc(e)';).   
 
The output lists the reaction with highest flux value for producing or consuming a 
defined metabolite across analyzed samples (*maximum_contributing_rxn*, 
*maximum_contributing_flux*) to simplify the analysis over large groups of 
samples (and metabolites of interest). Detailed results of the analysis are added to 
*ResultsAllCellLines*. 
 
E) Sampling the steady-state solution space 
Use the function performSampling to sample the solution space of a model:  
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>> performSampling(model, warmupn, fileName, nFiles, pointsPerFile, 
stepsPerPoint, fileBaseNo, maxTime, path); 
 
The function is based on COBRA toolbox, refer to the corresponding protocol for 
details [29]. Subsequently, use the function summarizeSamplingResults: 
 
>>  [stats, statsR] = summarizeSamplingResults(modelA, modelB, path, nFiles, 
pointsPerFile, starting_Model, dataGenes, show_rxns, fonts); 
 
Inspect the histograms automatically saved to the user-defined location (*path*, 
Figure 8, supplemental material). If the distributions are not unimodal (only 
bounded reactions will reach this, but not loop reactions (see Box 1), generate more 
sample points by using points from the last file as starting point (see tutorial_I). 
Analyze the results: Are the distributions shifted apart for any reactions or pathways 
that were expected or unexpected for a certain condition or group of samples? Make 
sure that your interpretations do not rely on unbounded reactions (Figure 8). 
 
F) Predict behavior to environmental changes 
Use the function performPPP to predict the simultaneous variation of two 
parameters (*mets*) at a time and for one or more submodels (*samples* in 
*ResultsAllCellLines*). Define the range of flux rates (uptake or secretion defined 
in *direct*) through the variables *step_size* (flux units) and number of steps 
*step_num*. This can be individually defined for each exchange reaction. The 
output is added to *ResultsAllCellLines*. 
 
>>  [ResultsAllCellLines] = performPPP(ResultsAllCellLines, mets, step_size, 
samples, step_num, direct); 
 
Illustrate your results with heat-maps using the function illustrate_ppp.  
 
>>  illustrate_ppp(ResultsAllCellLines, mets, path, samples, label, fonts, tol);  
 
The heat maps are saved to the defined *path*. The function uses flux variability 
analysis [29, 60], and the zero cutoff (*tol*, e.g., 1e-8) needs to be specified. The 
function allows some additional inputs, i.e., label and font size (*label*, *fonts*), 
to customize the illustrations. Analyze the output, e.g., by manually grouping the 
models based on the similarity of the planes in the heat maps (e.g., size and shape).  
 
18)  Validate the predicted, metabolic phenotypes 
 
A) Compare to experimental data 
Compare the results of the previous steps to data sets, e.g., cell culture and 
perturbation experiments, or compare the predictions to the results of the analysis 
of additional omics data, e.g., mRNA. Does regulation in metabolic genes support 
predicted metabolic differences between cells or conditions?  
 
B) Compare to literature 
Check if the results of the predictions generated in the previous step agree with what 
is reported in the literature. For example, has the cell line been previously reported 
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to heavily rely on an alternative pathway, e.g., reverse flux through the citric acid 
cycle? Are the essential genes already known to be essential in this cell type, or 
under the experimental conditions, such as hypoxia? 
 
5. Trouble Shooting 
 
Step 1: Metabolites cannot be associated with model metabolites. Exclude metabolites, 
which are not part of the model. Leaving out constraints has as consequence that 
physiologically irrelevant flux distributions (network states) may remain part of the steady-
state solution space. However, no wrong flux distributions are introduced! Another solution 
would be to add demand reactions (see Box 1) [43] that ‘artificially’ remove metabolites from 
the system, which were experimentally consumed but that could not be consumed by the model. 
A sink reaction (see Box 1) [43] could be included to represent an intracellular source for a 
metabolite, which cannot be produced by the model. However, such reactions have only an 
effect on the model if, e.g., the transport of the metabolite is dependent on energy or other 
substrates and might otherwise also be ignored. The consecutive addition of demand and sink 
reactions is not recommended. 
 
Step 2: Exchange reactions are constrained although the formula indicates that they are 
reversible. Change reaction bounds on the transport reaction using the function 
changeRxnBounds. Reactions might be closed to prevent thermodynamically infeasible cycles. 
Opening these reactions might lead to a leaking model (i.e., the model is able to produce 
metabolites, such as ATP without substrates). Thus, the model should be tested for leakage 
before proceeding to further steps (see [43]).  
 
Step 3: Transporter is unknown. Add a diffusion reaction. 
 
Step 4: Existing reactions need to be modified. New substrates have been identified for 
an existing transporter. Add, replace, or modify reactions if literature provides novel, 
convincing clues on the metabolite transport mechanisms. If diffusion is unlikely for a 
metabolite, consider removing the diffusion reaction that allow the transport ‘for free’. Add a 
reaction if the metabolite constitutes an additional substrate to an existing transporter. Make 
sure that the new substrate is transported in the same way as the original one before duplicating 
the reaction. Does the reaction mechanism correspond to that in the model? Check if the 
reaction stoichiometry, directionality, co-substrates, genes, and Gene-protein-reaction 
association (GPR) of the existing reaction agrees with your notes. Add the reaction with a new 
name corresponding to the transported metabolite. If the transport mechanism is different from 
the reaction mechanism already present in the model (particularly for diffusion reactions), 
review whether the original reaction needs to be updated based on the novel literature clues.  
The mechanism might have been better resolved since the original reconstruction (see 
references associated with the reaction, e.g., VMH database for the human genome scale 
reconstruction, https://vmh.uni.lu/). Correct the original reaction in the model based on the 
result of the literature review. Remove diffusion reactions if no longer adequate. 
 
Step 5: Identify minimal set of exchanges for a model and objective. Use flux variability 
analysis (FVA) to identify mandatory metabolite uptakes (negative non-zero minimal and 
maximal flux). 
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Step 7: Detection limits are unavailable. An arbitrary low value may be used to set the upper 
bounds on uptake fluxes and lower bounds on secretion fluxes that is close to the cutoff value 
(e.g., -0.00001/0.00001).   
 
Step 13: Generate metabolic fluxes. Use the function conc2rate to convert concentration 
changes (*metConc*) measured over the time course of the experiment (*t*), for a certain 
number of cells (*cellConc*), and dry weight (*cellWeight*) into flux (*flux*).  
 
>> [flux] = conc2Rate(metConc, cellConc, t, cellWeight);  
 
Step 16B: Constraints are too small and fall below the error range and/or exceed the 
infinite bounds (COBRA toolbox default is 1e-8). 
Multiply or divide all reaction bounds (except infinite constraints) with the same factor. Adjust 
the unit the fluxes accordingly using the same factor. Scale the unit the fluxes are reported in 
with the same factor. Repeat the previous steps to apply the reconciled constraints. If scaling 
is not possible because the range of fluxes is too wide (e.g., -1000 to 1000), the infinite bounds 
can be increased (setMediumConstraints). 
 
Step 16C: Additional metabolite exchanges are unlikely from a biological point of view. 
Close exchange reaction in the starting model and repeat the model building by 
setQuantConstraints (or generateCompactExchModel). 
 
Step 16D: The model contains unexpected pathways. Keep in mind that the integration of 
metabolomics data only indirectly causes the removal of metabolic pathway. Pathways are only 
removed if they become blocked as a consequence of exchanges being closed. An additional 
reduction of the internal metabolic network can be achieved by the integration of additional 
omics data sets, if the imposed flux rates are not deterministic enough. The contextualized 
models miss central features of the cells or certain metabolic functions cannot be 
performed. Note that the models constructed herein are condition-specific. Are the reported 
pathways really active in the considered experimental condition? Identify whether there is an 
exchange connected to the pathway, which is not defined by the consumed metabolites. Could 
these be missing from set of targeted metabolites? You can add the metabolite to the medium 
composition (e.g.,*ambiguous_metabolites*) to prevent that it is removed during model 
building. Iterate until models are conform to the expectation.  
 
Step 17: Generate the variables ResultsAllCellLines and OverViewResults to collect the 
information of the downstream analysis for models not generated herein. For models of 
name *model*, *model2*, … loaded in the workspace, execute: 
 
>>  samples = {'model', 'model2', …}; 
>>    for i=1:length(samples) 
>>      model_name= samples{i} 
>>      eval(['ResultsAllCellLines.' model_name '.modelMin =' model_name]); 
>>      eval(['ResultsAllCellLines.' model_name '.modelPruned =' model_name]); 
>>   end 
 
The difference between the models is that the *modelMin* has all reactions, whereas the 
pruned model is the reduced model. If only one exist, both can be equal. In the workflow the 
*modelMin* is used for the single gene deletion, instead of the *modelPruned*. 
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To generate the variable OverViewResults, execute: 
>>  samples = {'model', 'model2'}; 
>>   cntO=1; 
>>   OverViewResults{1,cntO} ='samples';  
>>   for i=1:length(samples) 
>>    OverViewResults{i+1,cntO} = samples{i}; 
>>   end 
 
Some of the analysis require the specification of a generic model, which is a superset of the 
models specified in *samples*.  
 
6. Timing 
Step 1, Map metabolite identifiers to Recon IDs, Timing: ~hours 
Step 2, Find which metabolites cannot be transported in the model, Timing: ~minutes  
Step 3, Identify missing metabolite transporter, Timing: depends on number ~ hours - days 
Step 4, Add reactions, Timing: ~hours 
Step 5, Define medium constraints, Computational Time: ~seconds 
Step 6, Calculate detection limits, Computational Time: ~seconds 
Step 7, Define uptake and secretion profiles, Computational Time: ~seconds 
Step 8, Calculate semi-quantitative differences, Computational Time: ~seconds 
Step 9, Set qualitative constraints, Computational Time: ~seconds 
Step 10, Apply semi-quantitative differences, Computational Time: ~seconds 
Step 11, Obtain uptake and secretion profiles (flux rates), Computational Time: ~seconds 
Step 12, Check the exchange profiles, Computational Time: ~seconds 
Step 13, Integrate quantitative constraints and generate minimal exchange model, 
Computational Time: ~minutes per model 
Step 14, Generate the subnetwork by pruning model, Computational Time: ~minutes 
Step 15, Integrate gene expression data, Computational Time: ~seconds 
 
Step 16, Validate the model, Timing: ~ days to weeks 
A) Literatue review to create an expectation, Timing: ~ days to weeks 
B) Check constraints, Timing: ~ minutes to hours 
C) Analyze added exchanges, Timing: ~ minutes to hours 
D) Check metabolic functions, Timing: ~ minutes to hours 
E) Comparison to experimental data, Timing: ~ days to weeks 
F) Test growth rates, Computational Time: ~ seconds  
 
Step 17, predict metabolic phenotypes, Timing: ~ hours to weeks 
A) Define essential genes, Computational Time: ~ minutes  
B) Identify essential reactions behind the gene essentiality, Computational 
Time: ~seconds 
C) Generate intersect and union model, Computational Time: ~seconds to 
minutes 
D) Predict flux splits, Computational Time: ~seconds per model 
E) Sampling the steady-state solution space, Computational Time: ~hours to 
days per model 
F) Predict behavior to environmental changes, Computational Time: 
~minutes to hours per model 
 
Step 18, Validate predicted, metabolic phenotypes, Timing: ~ days to weeks (or months) 
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Figure Legends 
 
Figure 1: This protocol and the MetaboTools provide comprehensive support for 
integration of extracellular metabolomic data and for the analysis and phenotypic 
stratification of metabolic models. The workflow captures the integration of processed and 
annotated metabolomic data sets, the generation of contextualized submodels, and the 
computational model analysis to distinguish metabolic phenotypes. The individual divided into 
small sections and form a step-by-step procedure discussed in detail in the protocol. The 
tutorials (supplementary tutorial I & II) demonstrate two use-cases of the workflow and 
MetaboTools.  
 
  
Figure 2: Stage 1 - Preparations for the integration of the metabolomic data. A. First, the 
detected metabolites need to be matched to the metabolite ID used in the model. This step is 
simplified if the metabolomic data are annotated with standard metabolite IDs (e.g., from 
KEGG [39] or HMDB [41]). B. Check if transport and exchange reactions exist in the model 
for each of the matched metabolites using the model metabolite ID. In case of the human 
genome-scale reconstruction (Recon 2 [35], you can check for reactions using the virtual 
metabolic human  database (VMH, https://vmh.uni.lu/) or directly in your model with the 
COBRA toolbox function findRxnsFromMets. The illustrated VMH query for glutamine shows 
two of the glutamine transport reactions (highlighted in blue) and the exchange reaction 
(highlighted in green) of glutamine. Exchange reactions are by definition written as in the given 
example. C. Transport reactions need to be identified as comprehensively as possible from the 
literature. Based on the information gathered about the transport mechanisms, by which a 
metabolite is transported into and out of the cell, the transport reactions can be formulated. The 
transport and exchange reactions can be added to the model using rBioNet [46]. 
 
 
Figure 3: Shaping the model to predict condition-specific metabolic states (contextualized 
model). A. In order for the model to follow the measured metabolite uptake and secretion 
profile, both exchange reactions and transport reactions need to be present to force the 
metabolite into (uptake) and out of the model (secretion). If those do not exist in the model, the 
transporters along with the mechanisms need to be identified in order to allow the model to 
follow the uptake and secretion profile of the experimental data. B. The uptake of metabolites 
is constrained based on the concentrations of metabolites available to the conditions that should 
be investigated. For example, the composition of defined experimental medium can be used. 
Also, the maximum uptake per cell and time unit can be calculated from the concentrations of 
nutrients, the concentration of cells, the cell weight, and the duration of the experiment. 
Otherwise, those constraints would be infinite and relative differences in the metabolite uptake 
would be less bound to the actual environmental conditions one wants to investigate. C. 
Metabolomics data are mapped as constraints to the exchange reactions. Glutamine, 
glyceraldehyde, and citrulline have to be secreted by the model. D. Transcriptomic or 
proteomic data are mapped to the internal network reactions (qualitatively), restricting which 
reactions a cell can use to transport and metabolize the metabolize, e.g., the enforced secretion 
of glutamine.  
 
Figure 4: Application of constraints on the bounds of exchange reactions. Infinite bounds 
(here, -1000 to 1000) express the unlimited supply and removal of metabolites to and from the 
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system. A negative flux through an exchange reactions corresponds to an uptake (red) and a 
positive flux corresponds to the secretion of a metabolite (blue). Maximal uptake can be 
constraint by restricting the lower bound (lb = -600). The directionality of the exchange can be 
defined by setting a negative value as the upper bound (ub) for an uptake or by setting a positive 
value as the lower bound for secretion. These constraints could be based on the limit of 
detection (LOD) or quantification for the metabolite. Relative differences in the uptake and 
secretion of a metabolite can be expressed as the relative difference from maximal possible 
uptake rate (purple as compared to red) and as the relative difference from the minimal 
secretion rate. Absolute concentration changes over time can be converted to flux values and 
added to the constraints, considering a user-defined error to the flux to define lower bound and 
upper bound. 
 
 
Figure 5: Applying semi-quantitative constraints. Relative differences in the uptake and 
secretion of metabolites from and into the extracellular medium can be imposed on the models, 
emphasizing the differences in metabolite uptake and secretion between samples. A. A slope 
ratio is calculated based on the data as the relative difference in uptake of a metabolite between 
two samples and compared to the control (medium). Flux values are in the unit of mmol/gdry 
weigth/hr. The result of the preparation is a set of new lower bounds, which can be applied to the 
model. Note that the adjusted bound is the grey number, whereas the orange number constitutes 
the flux value, which was defined based on the medium composition (negative bounds for 
maximal possible uptake) or based on the minimal detection limits (positive numbers for 
minimal possible secretion). B. Illustration of the trend in quantitative differences glucose 
between cell lines.  A difference in the measured intensity can be observed between time point 
0 and 48 hr. The signal also decreases in the control (medium). C. Relative differences of 
metabolite uptake and secretion are translated into relative differences of the constraints on 
exchange reactions of the cell line models, forcing the models to consume or release 
metabolites in the same relation as observed experimentally. 
 
Figure 6: Heat-map depicting differences in single gene deletion across 120 NCI-60 cell 
line models. The growth ratio is defined as the maximal objective value of the model divided 
by the maximal objective value of the model when the gene was deleted when optimizing for 
biomass production. Genes that were absent in individual models have a growth ratio value of 
-1. Genes that were absent in all models and genes whose deletion did not affect any model are 
not illustrated. The coloring in the heat-map corresponds to the maximal objective values 
obtained from flux balance analysis at each step of the analysis.  
 
Figure 7: Models can be stratisfied based into distinct metabolic phenotypes on the 
pathway that they use prevailingly.  
 
Figure 8: Interpreting the results of the sampling analysis. A. During the sampling analysis, 
a large set of sampling points is collected (red dots, each comprising a flux distribution). The 
fluxes collected from the sampling points can be illustrated as probability distribution for 
individual reactions. B. Comparing the histograms of the probability flux distributions through 
the glutamine exchange reaction in two models (blue and green) reveals a shift of the feasible 
steady-state solution space for this reaction. C. The irregular histogram is typical for an 
unbounded reaction (distribution ranges from -1000 to 1000). D. A premature flux distribution 
of the glutamine exchange reaction. Even though the final shape of the distributions can be 
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guessed, additional sampling points need to be generated to get a unimodal distribution of the 
fluxes. Generation of additional points could shift the distribution. U= flux units. 
 
 
 
 
 
 
 
 
 
Tables  
Table 1: Additional data used for the intra-model analysis of metabolomic data. 
Data type  Unit Use case I: Semi-
quantitative data 
Use case II: 
Quantitative data 
Cell medium 
composition  
(e.g., RPMI medium) 
 mM yes no 
Concentration of 
Ions, and other 
compounds (e.g., O2, 
CO2) 
mM O2 defined based 
on literature. 
O2 defined based on 
literature for one of 
the cell lines. 
Cell-weight  preferable gdry weight experimental 
measurement 
defined based on 
literature for one of 
the cell lines 
Cell count  cells per ml experimental 
measurement 
not required 
Experimental 
duration (in hours) 
 experimental 
duration 
not required 
Detection limits for 
all detected 
metabolites (mass 
spectrometer) 
instrumental limit of 
detection in ng/mL 
or LODs in mM 
experimental 
measurement 
not required 
Doubling time  hours or growth rate experimental 
measurement 
defined in the 
experiment if possible 
Transcriptomic or 
proteomic data 
list of absent genes experimental 
measurement 
from the same 
experiment 
not required 
 
 
Table 2: Test case illustrating possible loophole in the reaction constraints. 
Test case:  Missing constraints 
Expectation A human model requires oxygen, no 
constraints are applied to oxygen 
exchange. 
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Reality  Contextualized models secrete oxygen. 
 
Consequence Additional constraints need to be applied 
to prevent oxygen secretion. 
 
 
 
 
Table 3: Use expectations to compare the generated models against. The table lists 
examples of questions and data that can be used to validate contextualized models along with 
existing examples and MetaboTools functions that can be used for this analysis. 
Question to address for 
model validation 
Example used in Leukemia 
cell lines [7] or NCI-60 cell 
lines [32] 
Check using 
MetaboTools*, models, or 
alternative resource 
What metabolic pathways 
does/ does my model include 
that would (not) be expected 
for the target cell?  
Transcriptomic data 
integration caused absence 
of complex I of the electron 
transport chain in the 
models, which complied 
with literature [7]. 
model.subsystems, 
model.rxns 
metabolic functions [35] 
To what extend does the 
model capture metabolites 
detected in the intracellular 
metabolome? 
 model.mets 
Are the models able to 
achieve experimental growth 
rates given the applied 
constraints? 
-Analysis was conducted 
using biomass constraints 
[7]. 
-The vast majority of the 
models was able to grow at 
experimental growth rates 
[32]. 
setConstraintsOnBiomassR
eaction* or 
changeRxnBounds (add 
constraint) 
optimizeCbModel (perform 
FBA) 
(changeObejctive – set 
objective function in 
model.c) 
Which exchange reactions 
have been added? Are the 
cells known to use/ secrete 
these substrates?  
Cancer cells are known to 
use fatty acids to support 
their growth [32]. 
statisticsAddedExchanges* 
 
Table 4: Questions to guide the analysis of predicted sets of essential genes.  
 
Purpose Question 
Stratify 
models into 
groups 
How much does the number of essential genes vary across 
models? Does this variation coincide with model size or growth 
rates, or with phenotypes predicted by another analysis?  
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Which genes are essential only in a small subset of the 
submodels? Which essential genes affect all models in the set of 
model? 
 Are the essential genes directly connected to an enforced 
metabolite exchanges? 
Validation, 
generate 
testable 
hypothesis 
Are the predicted essential genes known or already used for 
therapeutical purposes? 
Generate 
testable 
hypothesis 
Do you find interesting essential genes, pathways affected in 
single models or model groups? Could predicted essential genes 
constitute interesting targets (e.g., drug targets)? 
Boxes  
Box 1 
Glossary  
Antimetabolite – structurally similar metabolite that inhibits the use of the original 
metabolite by an enzyme and thus, can diminish proliferation.  
Cell-type or tissue-specific model – model that contains all reactions and pathways a 
cell type or tissue can use in under any set of environmental and/or genetic condition. 
A condition-specific model contains a subset of reactions of the cell-type or tissue-
specific model.  
Closed exchange reaction – reaction, whose lower and upper bounds are set to zero 
and which, due to these constraints, cannot carry any flux (flux value is zero). 
Constraints – limits set on reactions in the metabolic model and defined through the 
upper bound (‘ub’) and lower bound (‘lb’) variable vector in the model. Possible 
computed flux values for a reaction can only lie between or on these bounds. 
Contextualized model – model that has been tailored towards a particular experimental 
condition. 
Data integration – applying constraints based on experimental (e.g., high-throughput) 
measurements. 
Data mapping – matching names of the metabolites in the reconstruction and the data. 
Demand reaction – unbalanced network reactions, which allow accumulation of  
metabolites in the model and as such circumvent the steady-state assumption 
underlying constraint-based modeling. 
Exchange profile – the profile of a sample (e.g., cell line, hypoxic condition, etc.), 
detailing, which metabolites are consumed and which metabolites are released. It will 
be used to established constraints during the data integration process.  
Feasible model – a model that can satisfy the user-defined objective function while 
being consistent with the applied constraints. 
Gap-filling approaches – predict possible ways to fill network gaps using pathway 
and reaction information from other organisms. 
Generic model – a model that captures all metabolic functions and pathways known to 
be active in at least one cell and/or under at least one condition in organism. 
Gene-protein-reaction association (GPRs) - a reaction is associated with one or more 
genes encoding for one or more enzymes, which catalyze the reaction. The gene-
protein-reaction associations are formulated as Boolean rules, whereby isozymes are 
associated with an OR and subunits of the functional protein complex are associated 
with an AND in the GPRs. 
Infinite constraint – an arbitrary high value that does not limit reaction flux. 
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Loop reactions – cyclic internal reactions that do not depend on the inputs and outputs 
of the model. Loop reactions are thermodynamically infeasible and common artifacts 
in metabolic models due to missing constraints (e.g., temporal separation of pathways, 
regulation). 
Open model – all exchange reactions in the model are unconstrained. 
Sample – one experimental condition. 
Sampling point – each sampling point contains an entire flux vector, and thus contains 
a flux value for each reactions in the metabolic model. 
Sink reaction – adds compounds that cannot be produced by the metabolic model, 
because they originate from pathways outside metabolism or because the production 
pathways are unknown.  
Steady-state assumption – the modeled system is assumed to be in steady state, i.e., 
no metabolites are accumulated over time (dx/dt = 0). 
Unbounded reactions – reactions, whose fluxes are not limited through the network 
topology and applied constraints, but which expand over the entire span between the 
constraints (i.e., infinite bounds).  
Unconstrained – the upper and lower bounds are set to infinite. 
 
 
Supplementary data 
1. Supplementary material (text) 
1.1 The model structure in matlab 
1.2 Infinite constraints 
1.3 Why use minExCard? 
1.4 Conversion of the theoretical mass 
1.5 Calculate weight and obtain dry weight 
1.6 Generate metabolic fluxes 
1.7 Additional on scaling of infinite bounds and defined constraints 
1.8 Additional remarks on the integration of Gene Expression data 
1.9 Additional remarks on “Sampling the solution space” 
 
Supplementary Figure 1: Structure in the human metabolic model. 
 
Supplementary Table 1: Appeal from a computational biologist to the 
metabolomics community. The table lists points that simplify the integration 
of metabolomics data sets into the model context. 
 
 
2. Supplementary Tutorial I: Workflow for the integration of semi-quantitative 
extracellular metabolomic data into the network context. 
3. Supplementary Tutorial II: Workflow for the integration of quantitative 
extracellular metabolomic data into the network context. 
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